Search Results - "López, Giselle Y"

Refine Results
  1. 1

    Management of glioblastoma: State of the art and future directions by Tan, Aaron C., Ashley, David M., López, Giselle Y., Malinzak, Michael, Friedman, Henry S., Khasraw, Mustafa

    Published in CA: a cancer journal for clinicians (01-07-2020)
    “…Glioblastoma is the most common malignant primary brain tumor. Overall, the prognosis for patients with this disease is poor, with a median survival of <2…”
    Get full text
    Journal Article
  2. 2

    Polio virotherapy targets the malignant glioma myeloid infiltrate with diffuse microglia activation engulfing the CNS by Yang, Yuanfan, Brown, Michael C, Zhang, Gao, Stevenson, Kevin, Mohme, Malte, Kornahrens, Reb, Bigner, Darell D, Ashley, David M, López, Giselle Y, Gromeier, Matthias

    Published in Neuro-oncology (Charlottesville, Va.) (05-09-2023)
    “…Abstract Background Malignant gliomas commandeer dense inflammatory infiltrates with glioma-associated macrophages and microglia (GAMM) promoting immune…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Proinflammatory cytokines and ARDS pulmonary edema fluid induce CD40 on human mesenchymal stromal cells-A potential mechanism for immune modulation by Wilfong, Erin M, Croze, Roxanne, Fang, Xiaohui, Schwede, Matthew, Niemi, Erene, López, Giselle Y, Lee, Jae-Woo, Nakamura, Mary C, Matthay, Michael A

    Published in PloS one (06-10-2020)
    “…Human mesenchymal stem/stromal cells (hMSCs) are a promising therapy for acute respiratory distress syndrome (ARDS) and other inflammatory conditions. While…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies by Shen, Erica, Xiu, Joanne, Bentley, Rex, López, Giselle Y., Walsh, Kyle M.

    Published in Clinical lung cancer (01-11-2020)
    “…Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of non–small-cell lung cancer (NSCLC) harboring mutations in many canonical NSCLC-driver genes (eg,…”
    Get full text
    Journal Article
  7. 7

    Spatial transcriptomics reveals segregation of tumor cell states in glioblastoma and marked immunosuppression within the perinecrotic niche by Liu, Mengyi, Ji, Zhicheng, Jain, Vaibhav, Smith, Vanessa L, Hocke, Emily, Patel, Anoop P, McLendon, Roger E, Ashley, David M, Gregory, Simon G, López, Giselle Y

    Published in Acta neuropathologica communications (22-04-2024)
    “…Glioblastoma (GBM) remains an untreatable malignant tumor with poor patient outcomes, characterized by palisading necrosis and microvascular proliferation…”
    Get full text
    Journal Article
  8. 8

    Ganglioglioma deep transcriptomics reveals primitive neuroectoderm neural precursor-like population by Regal, Joshua A, Guerra García, María E, Jain, Vaibhav, Chandramohan, Vidyalakshmi, Ashley, David M, Gregory, Simon G, Thompson, Eric M, López, Giselle Y, Reitman, Zachary J

    Published in Acta neuropathologica communications (25-03-2023)
    “…Gangliogliomas are brain tumors composed of neuron-like and macroglia-like components that occur in children and young adults. Gangliogliomas are often…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Perilesional edema associated with an intracranial calcifying pseudoneoplasm of the neuraxis in a child: case report and review of imaging features by Safaee, Michael M, Jonzzon, Soren, López, Giselle Y, Asaikar, Shailesh, Tihan, Tarik, Glenn, Orit A, Gupta, Nalin

    Published in Journal of neurosurgery. Pediatrics (01-11-2018)
    “…Calcifying pseudoneoplasms of the neuraxis (CAPNONs) are rare, nonneoplastic lesions of the CNS. Their radiographic features have been well described, with…”
    Get full text
    Journal Article
  11. 11

    Eosinophilic globules in a classic ependymoma: evidence of a possible secretory role by Ahn, Janice S, Petersen, Maureen, Friedman, Allan H, López, Edward M, Cummings, Thomas J, Buckley, Anne F, López, Giselle Y

    Published in Ultrastructural pathology (20-11-2020)
    “…A number of neoplasms of the central nervous system can demonstrate diffuse eosinophilic globules, known to be secretory products of the corresponding cell…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report by Fan, Joline M, Solomon, David A, López, Giselle Y, Hofmann, Jeffrey W, Colorado, Rene A, Kim, Anthony S, Meisel, Karl, Halabi, Cathra

    Published in BMC neurology (21-03-2020)
    “…Psoriasis is the most common chronic inflammatory condition involving the T helper cell system. Population studies have demonstrated that patients with…”
    Get full text
    Journal Article
  14. 14

    Disruption of Wild-Type IDH1 Suppresses D-2-Hydroxyglutarate Production in IDH1-Mutated Gliomas by GENGLIN JIN, REITMAN, Zachary J, BIGNER, Darell D, HAI YAN, DUNCAN, Christopher G, SPASOJEVIC, Ivan, GOODEN, David M, AHMED RASHEED, B, RUI YANG, LOPEZ, Giselle Y, YIPING HE, MCLENDON, Roger E

    Published in Cancer research (Chicago, Ill.) (15-01-2013)
    “…Point mutations at Arg132 of the cytoplasmic NADP(+)-dependent isocitrate dehydrogenase 1 (IDH1) occur frequently in gliomas and result in a gain of function…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Mutant IDH1 is required for IDH1 mutated tumor cell growth by Jin, Genglin, Pirozzi, Christopher J, Chen, Lee H, Lopez, Giselle Y, Duncan, Christopher G, Feng, Jie, Spasojevic, Ivan, Bigner, Darell D, He, Yiping, Yan, Hai

    Published in Oncotarget (01-08-2012)
    “…Frequent somatic hotspot mutations in isocitrate dehydrogenase 1 (IDH1) have been identified in gliomas, acute myeloid leukemias, chondrosarcomas, and other…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target by Guo, Changcun, Pirozzi, Christopher J, Lopez, Giselle Y, Yan, Hai

    Published in Current opinion in neurology (01-12-2011)
    “…Isocitrate dehydrogenases, IDH1 and IDH2, decarboxylate isocitrate to α-ketoglutarate (α-KG) and reduce NADP to NADPH. Point mutations of IDH1 and IDH2 have…”
    Get full text
    Journal Article
  19. 19
  20. 20

    IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain by Lopez, Giselle Y, Reitman, Zachary J, Solomon, David, Waldman, Todd, Bigner, Darell D, McLendon, Roger E, Rosenberg, Steven A, Samuels, Yardena, Yan, Hai

    “…Isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) are enzymes which convert isocitrate to alpha-ketoglutarate while reducing nicotinamide…”
    Get full text
    Journal Article